Abstract
The analysis of genome-wide epigenomic alterations including DNA methylation and hydroxymethylation has become a subject of intensive research for many biological and disease-associated investigations. Whole-genome bisulfite sequencing (WGBS) using next-generation sequencing technologies is currently considered as the gold standard for a comprehensive and quantitative analysis of DNA methylation throughout the genome. However, bisulfite conversion does not allow distinguishing between cytosine methylation and hydroxymethylation requiring an additional chemical or enzymatic step to identify hydroxymethylated cytosines. Here we provide two detailed protocols based on commercial kits for the preparation of sequencing libraries for the comprehensive whole-genome analysis of DNA methylation and/or hydroxymethylation. If only DNA methylation is of interest, sequencing libraries can be constructed from limited amounts of input DNA by ligation of methylated adaptors to the fragmented DNA prior to bisulfite conversion. For samples with significant levels of hydroxymethylation such as stem cells or brain tissue, we describe the protocol of oxidative bisulfite sequencing (OxBs-seq), which in its current version uses a post-bisulfite adaptor tagging (PBAT) approach. Two methylomes need to be generated: a classic methylome following bisulfite conversion and analyzing both methylated and hydroxymethylated cytosines and a methylome analyzing only methylated cytosines, respectively. We also provide a step-by-step description of the data analysis using publicly available bioinformatic tools. The described protocols have been successfully applied to different human samples and yield robust and reproducible results.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
How Kit A, Nielsen HM, Tost J (2012) DNA methylation based biomarkers: practical considerations and applications. Biochimie 94:2314–2337
Baylin SB, Jones PA (2011) A decade of exploring the cancer epigenome – biological and translational implications. Nat Rev Cancer 11:726–734
Lardenoije R, Iatrou A, Kenis G et al (2015) The epigenetics of aging and neurodegeneration. Prog Neurobiol 131:21–64
Nielsen HM, Tost J (2012) Epigenetic changes in inflammatory and autoimmune diseases. Subcell Biochem 61:455–478
Harb H, Renz H (2015) Update on epigenetics in allergic disease. J Allergy Clin Immunol 135:15–24
Zhang Z, Zhang R (2015) Epigenetics in autoimmune diseases: pathogenesis and prospects for therapy. Autoimmun Rev 14:854–863
Shorter KR, Miller BH (2015) Epigenetic mechanisms in schizophrenia. Prog Biophys Mol Biol 118:1–7
Abdolmaleky HM, Zhou JR, Thiagalingam S (2015) An update on the epigenetics of psychotic diseases and autism. Epigenomics 7:427–449
Ronn T, Ling C (2015) DNA methylation as a diagnostic and therapeutic target in the battle against type 2 diabetes. Epigenomics 7:451–460
Urich MA, Nery JR, Lister R et al (2015) MethylC-seq library preparation for base-resolution whole-genome bisulfite sequencing. Nat Protoc 10:475–483
Kobayashi H, Sakurai T, Imai M et al (2012) Contribution of intragenic DNA methylation in mouse gametic DNA methylomes to establish oocyte-specific heritable marks. PLoS Genet 8:e1002440
Adusumalli S, Mohd Omar MF, Soong R et al (2015) Methodological aspects of whole-genome bisulfite sequencing analysis. Brief Bioinform 16:369–379
Lister R, Pelizzola M, Dowen RH et al (2009) Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462:315–322
Lister R, O'Malley RC, Tonti-Filippini J et al (2008) Highly integrated single-base resolution maps of the epigenome in Arabidopsis. Cell 133:523–536
Lister R, Pelizzola M, Kida YS et al (2011) Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471:68–73
Li Y, Zhu J, Tian G et al (2010) The DNA methylome of human peripheral blood mononuclear cells. PLoS Biol 8:e1000533
Chalhoub B, Denoeud F, Liu S et al (2014) Plant genetics. Early allopolyploid evolution in the post-Neolithic Brassica napus oilseed genome. Science 345:950–953
Lyko F, Foret S, Kucharski R et al (2010) The honey bee epigenomes: differential methylation of brain DNA in queens and workers. PLoS Biol 8:e1000506
Guo JU, Su Y, Shin JH et al (2014) Distribution, recognition and regulation of non-CpG methylation in the adult mammalian brain. Nat Neurosci 17:215–222
Adey A, Shendure J (2012) Ultra-low-input, tagmentation-based whole-genome bisulfite sequencing. Genome Res 22:1139–1143
Miura F, Enomoto Y, Dairiki R et al (2012) Amplification-free whole-genome bisulfite sequencing by post-bisulfite adaptor tagging. Nucleic Acids Res 40:e136
Kriaucionis S, Heintz N (2009) The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324:929–930
Tahiliani M, Koh KP, Shen Y et al (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324:930–935
Tan L, Shi YG (2012) Tet family proteins and 5-hydroxymethylcytosine in development and disease. Development 139:1895–1902
Ludwig AK, Zhang P, Cardoso MC (2016) Modifiers and readers of DNA modifications and their impact on genome structure, expression, and stability in disease. Front Genet 7:115
Wu SC, Zhang Y (2010) Active DNA demethylation: many roads lead to Rome. Nat Rev Mol Cell Biol 11:607–620
Ito S, Shen L, Dai Q et al (2011) Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333:1300–1303
Nestor CE, Ottaviano R, Reddington J et al (2012) Tissue type is a major modifier of the 5-hydroxymethylcytosine content of human genes. Genome Res 22:467–477
Langemeijer SM, Aslanyan MG, Jansen JH (2009) TET proteins in malignant hematopoiesis. Cell Cycle 8:4044–4048
Pastor WA, Pape UJ, Huang Y et al (2011) Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature 473:394–397
Ficz G, Branco MR, Seisenberger S et al (2011) Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 473:398–402
Jin SG, Wu X, Li AX et al (2011) Genomic mapping of 5-hydroxymethylcytosine in the human brain. Nucleic Acids Res 39:5015–5024
Ono R, Taki T, Taketani T et al (2002) LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23). Cancer Res 62:4075–4080
Mercher T, Quivoron C, Couronne L et al (2012) TET2, a tumor suppressor in hematological disorders. Biochim Biophys Acta 1825:173–177
Putiri EL, Tiedemann RL, Thompson JJ et al (2014) Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells. Genome Biol 15:R81
Jin SG, Jiang Y, Qiu R et al (2011) 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Res 71:7360–7365
Booth MJ, Branco MR, Ficz G et al (2012) Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution. Science 336:934–937
Yu M, Hon GC, Szulwach KE et al (2012) Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell 149:1368–1380
Skvortsova K, Zotenko E, Luu PL et al (2017) Comprehensive evaluation of genome-wide 5-hydroxymethylcytosine profiling approaches in human DNA. Epigenetics Chromatin 10:16
Song CX, Szulwach KE, Fu Y et al (2011) Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat Biotechnol 29:68–72
Daviaud C, Renault V, Mauger F et al (2018) Whole-genome bisulfite sequencing using the Ovation® Ultralow Methyl-Seq protocol. Methods Mol Biol 1708:83–104
Krueger F, Andrews SR (2011) Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics 27:1571–1572
Li H, Handsaker B, Wysoker A et al (2009) The sequence alignment/map format and SAMtools. Bioinformatics 25:2078–2079
Akalin A, Kormaksson M, Li S et al (2012) methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles. Genome Biol 13:R87
Acknowledgments
The protocol for hydroxymethylation analysis has been set up in the laboratory of Jörg Tost in the framework of the ANR-BMBF-funded project “Epigenomics of Parkinson’s Disease” (EpiPD, ANR-13-EPIG-0003-05). Further work is supported by grants from the ANR (ANR-13-CESA-0011-05), Aviesan/INSERM (EPlGl2014-18 and EPIG2014-01), INCa (PRT-K14-049), a Sirius research award (UCB Pharma S.A.), a Passerelle research award (Pfizer), iCARE (MSD Avenir), and the institutional budget of the CNRGH.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Kernaleguen, M. et al. (2018). Whole-Genome Bisulfite Sequencing for the Analysis of Genome-Wide DNA Methylation and Hydroxymethylation Patterns at Single-Nucleotide Resolution. In: Jeltsch, A., Rots, M. (eds) Epigenome Editing. Methods in Molecular Biology, vol 1767. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7774-1_18
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7774-1_18
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7773-4
Online ISBN: 978-1-4939-7774-1
eBook Packages: Springer Protocols